Site Search

... patients and survivors. In October 2019, Survivor Views conducted a cohort survey focused on their experiences accessing and paying for cancer care, including the cost of prescription drugs and their experiences receiving surprise bills. One thousand three hundred and ninety-two cohort ... confidence level. The research provides important insights into the experiences of cancer patients and survivors in accessing and affording health care and medication to treat their cancer or prevent it from returning.  Key Findings:  Key findings from the survey include: Nearly ... to try a less expensive drug first (also known as step therapy). Seventy-nine percent of respondents who reported a barrier experienced negative health or lifestyle consequences, including additional time spent resolving the issue, additional expense to obtain the drug, or difficulty ...

... that they are generally larger, more complex molecules. Biologics are usually administered via injection or infusion. Most biologics in cancer care are given under the close supervision of a medical professional.  Biologics have been a part of medical treatment for a long time and have ... one, some, or all of the conditions of the reference product. While the safety of a biosimilar is assured through FDA review and approval, your health care provider should review the product label for any prescribed biosimilar.  Why biosimilars were introduced Biosimilars were introduced ... to you by your healthcare provider. This might be for several reasons, including that the biosimilar is the preferred product of your doctor or health plan. This preference might also come from physician’s experience with the product, a desire by your health plan to control costs, or ...